BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1458 related articles for article (PubMed ID: 28863160)

  • 41. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.
    Grimsrud A; Balkan S; Casas EC; Lujan J; Van Cutsem G; Poulet E; Myer L; Pujades-Rodriguez M
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):e55-66. PubMed ID: 24977472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.
    Lamb MR; Fayorsey R; Nuwagaba-Biribonwoha H; Viola V; Mutabazi V; Alwar T; Casalini C; Elul B
    AIDS; 2014 Feb; 28(4):559-68. PubMed ID: 24076661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of mortality and loss to follow-up among adults enrolled in HIV care services in Rwanda.
    Mugisha V; Teasdale CA; Wang C; Lahuerta M; Nuwagaba-Biribonwoha H; Tayebwa E; Ingabire E; Ingabire P; Sahabo R; Twyman P; Abrams EJ;
    PLoS One; 2014; 9(1):e85774. PubMed ID: 24454931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
    Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
    PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
    Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
    PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.
    Teeraananchai S; Kerr SJ; Ruxrungtham K; Avihingsanon A; Chaivooth S; Teeraratkul A; Bhakeecheep S; Ongwandee S; Thanprasertsuk S; Law MG
    Antivir Ther; 2018; 23(6):529-538. PubMed ID: 29583122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004-2013.
    Angdembe MR; Rai A; Bam K; Pandey SR
    PLoS One; 2019; 14(4):e0215776. PubMed ID: 31013320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
    PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
    Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
    PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
    Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
    PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
    Ardura-Garcia C; Feldacker C; Tweya H; Chaweza T; Kalulu M; Phiri S; Wang D; Weigel R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):e160-7. PubMed ID: 26218409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa.
    Rachlis B; Bakoyannis G; Easterbrook P; Genberg B; Braithwaite RS; Cohen CR; Bukusi EA; Kambugu A; Bwana MB; Somi GR; Geng EH; Musick B; Yiannoutsos CT; Wools-Kaloustian K; Braitstein P
    PLoS One; 2016; 11(8):e0159994. PubMed ID: 27509182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.